Skip to main content
TipRanks
Go Ultimate75% OFF

IQVIA Holdings (QTS) Stock Price & Analysis

1 Followers

QTS Stock Chart & Stats

No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
N/A
Average Volume (3M)
N/A
Market Cap
CHF 34.70B
Enterprise Value
CHF 58.92B
Total Cash (Recent Filing)
CHF 2.42B
Total Debt (Recent Filing)
CHF 16.31B
Price to Earnings (P/E)
29.5
Beta
N/A
Next Earnings
Feb 11, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Steady Growth And Profitability

IQVIA has expanded revenue while sustaining healthy operating and net margins, indicating a resilient service model and effective cost control. This combination supports recurring investment in technology and delivery capabilities, giving the company a durable base for continued growth across the product lifecycle.

Clinical Demand And Bookings

Consistent bookings growth provides forward visibility for the clinical development business and validates customer demand for outsourced research services. Rising win rates, broad-based full-service demand, and a 1.2 book-to-bill can support revenue conversion and strengthen IQVIA’s market position over coming quarters.

AI And Technology Differentiation

Broad AI deployment can deepen IQVIA’s differentiation by improving clinical execution, shortening customer timelines, and enabling new technology-based services. Integration with proprietary healthcare data and established life-sciences relationships may increase customer value, support adoption, and create additional recurring revenue opportunities.

Bears Say

Elevated Leverage

High leverage reduces financial flexibility and leaves earnings and cash flow more exposed to refinancing conditions and interest costs. Although IQVIA generates substantial cash, debt service and maturity management can constrain acquisitions, technology investment, and the company’s ability to absorb weaker demand.

Inactive-Trial Backlog Reduction

The backlog reduction indicates that a meaningful portion of previously recorded clinical work is unlikely to resume soon, reducing the quality of headline backlog visibility. Management said it does not affect guidance or near-term revenue, but it highlights the need for disciplined backlog conversion and customer project monitoring.

Growth And Margin Pressure

Slower historical growth and a lower recent gross margin suggest that reported expansion may remain sensitive to business mix and cost pressures. Pass-through activity can dilute margins even when operations improve, making sustained profitability dependent on continued productivity gains and favorable service composition.

IQVIA Holdings News

QTS FAQ

What is IQVIA Holdings’s market cap?
IQVIA Holdings’s market cap is CHF34.70B.
When is IQVIA Holdings’s upcoming earnings report date?
IQVIA Holdings’s next earnings report is estimated for Feb 11, 2027 (not yet confirmed), which is in 82 days.
How were IQVIA Holdings’s earnings last quarter?
IQVIA Holdings released its earnings results on Oct 27, 2026. The company reported CHF2.818 earnings per share for the quarter, beating the consensus estimate of CHF2.75 by CHF0.068.
Is IQVIA Holdings overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does IQVIA Holdings pay dividends?
IQVIA Holdings does not currently pay dividends.
What is IQVIA Holdings’s EPS estimate?
IQVIA Holdings’s EPS estimate is 3.02.
What happened to IQVIA Holdings’s price movement after its last earnings report?
IQVIA Holdings reported an EPS of CHF2.818 in its last earnings report, beating expectations of CHF2.75. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of IQVIA Holdings?
Hedge funds hold IQVIA Holdings shares: the largest hedge-fund position in IQVIA Holdings is 915,615,772 shares, and hedge funds increased their holdings by 657.2K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology